August 3, 2017 -- The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients w
FRIDAY, July 28, 2017 -- The drug ketamine -- known as Special K on the party scene -- shows promise as a depression treatment. But researchers arent ready to recommend it because its long-term effects remain unknown.
That gap in knowledge must be fill
FRIDAY, July 28, 2017 -- The U.S. Food and Drug Administration will focus on reducing nicotine levels in cigarettes to make them less addictive, while also making other nicotine products -- including patches and gum -- safer, agency officials said Friday.
FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jul. 18, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vosevi (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a single-ta
FRIDAY, July 14, 2017 -- Get a good nights sleep and junk food may have less appeal at the end of a tough day.
Thats the suggestion of a study published online recently in the Journal of Applied Psychology.
"We found that employees who have a stress